Leerink Partners on OmniAb, Inc. (OABI): we see no change to OABI outlook from IMVT trial failure

Go back to Leerink Partners on OmniAb, Inc. (OABI): we see no change to OABI outlook from IMVT trial failure
(NASDAQ: OABI) Delayed: 2.50 -0.12 (4.58%)
Previous Close $2.62    52 Week High
Open $2.62    52 Week Low
Day High $2.63    P/E N/A 
Day Low $2.48    EPS
Volume 412,159